W2O announced two new products available through Symplur, the company’s social media analytics platform dedicated exclusively to the healthcare industry.
Walmart Inc., Walgreens Boots Alliance Inc., CVS Health Corp. and Rite Aid Corp. told Reuters demand for flu shots at their U.S. pharmacies is up sharply – in some cases double from 2019 – as people try to protect themselves from influenza in the midst of a worsening Covid-19 pandemic.
Thinking like a consumer marketer allows you to discover patients’ mindsets, how they operate daily, and how they move through their lives. This approach can bring a higher level of empathy and authenticity that attracts patients rather than having to chase them. Following these suggestions can help create a patient-centric media strategy that will appeal to your target audience, so they can make better decisions to improve their care and quality of life.
In this virtual discussion, Jefferson Health’s Chief Growth and Marketing Officer will explore how to shift the culture to one that is hyper-focused on profitable growth that improves patient lives.
New York state filed civil charges accusing Johnson & Johnson of insurance fraud for downplaying the risks of opioid painkillers, including to doctors and elderly patients.
Fernando Fernandez, Managing Director of FCB Health Network’s BX – Brand Experience Design Group, talked to Med Ad News about how COVID-19 has changed the way people interact with brands, how branding innovations such as audio and motion identities are making their way to pharma, and other topics.
Bryen Pittner, a Strategic Planner for FCB Health New York, discusses how healthcare brands can reach patients meaningfully at three key touchpoints in a simple transactional journey.
According to a new study by Worldwide Partners, the effect that Covid-19 is having on digital health adoption is set to be transformative. The survey that was conducted shows technology is playing a crucial and growing role in mitigating the healthcare crisis, especially via telehealth.
COVID-19 has changed nearly every aspect of healthcare as we know it. Pharmaceutical commercial organizations must quickly adapt to the present while simultaneously planning for a dramatically different future.
The COVID-19 global pandemic, overcrowding of hospitals, the highly contagious virus affecting healthcare professionals and unrelated illnesses has led to a more than 1,000 percent increase of telemed application downloads and memberships. Is this a paradigm shift?